Bitcoin, Taxes, & North Korea: What It Means For Stocks In 2018

• (1:00) - Bitcoin Surges To $10,000
• (5:00) - Trump's Tax Reform
• (10:10) - Jerome Powell's Fed Chair Testimony
• (13:40) - Tech Sector Selloff
• (21:30) - Episode Roundup: Podcast@Zacks.com

On today’s episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest stories, including the progress made on the GOP tax bill, North Korea’s missile test, bitcoin’s historic week, and what it all means for the stock market in 2018.

Make sure to subscribe and leave the show a rating on iTunes!

Throughout the week, investors reacted to a number of different headlines. From bitcoin reaching historic milestones, to North Korea testing new weapons and the Republicans making progress on their long-awaited tax bill, Wall Street has had plenty to grapple with.

With tax cuts in the pipeline, a new Fed chair set to be confirmed, heightening geopolitical tensions, and more attention than ever on the cryptocurrency market, there looks to be quite the busy ending to 2017.

We had already seen some of these headlines result in real effects. Bank stocks, led by JPMorgan (NYSE:JPM) and Bank of America (NYSE:BAC) were soaring this week, while tech behemoths, especially Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) , suffered a major selloff on Wednesday.

Maddy and Ryan discussed these effects and highlighted the key factors that could influence these stocks as we approach 2018.

Make sure to tune into the show to hear more!

As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on iTunes.

As always, thanks for listening to this episode of the Zacks Friday Finish Line, and check back for even more news from the investment and financial world!

Want more stock market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>